Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0–N1 nonsmall cell lung cancer and malignant pleural effusion?

INTRODUCTION: Debulking surgery and hyperthermic intrathoracic chemotherapy (HITHOC) has been successfully used in the treatment of thoracic tumours. Few authors report on the feasibility of its use in patients with lung cancer and malignant pleural effusion. The aim of this study was to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliore, Marcello, Nardini, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489167/
https://www.ncbi.nlm.nih.gov/pubmed/31366459
http://dx.doi.org/10.1183/16000617.0018-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489167/
https://www.ncbi.nlm.nih.gov/pubmed/31366459
http://dx.doi.org/10.1183/16000617.0018-2019

Ejemplares similares